Should we measure routinely oxidised and atherogenic dense low-density lipoproteins in subjects with type 2 diabetes?

Rizzo M, Berneis K, Koulouris S, Pastromas S, Rini GB, Sakellariou D, Manolis AS

Open source

DOI
10.1111/j.1742-1241.2010.02378.x
Published
2010 Nov
Container
International journal of clinical practice
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1111/j.1742-1241.2010.02378.x,
  title = {Should we measure routinely oxidised and atherogenic dense low-density lipoproteins in subjects with type 2 diabetes?},
  author = {Rizzo M and Berneis K and Koulouris S and Pastromas S and Rini GB and Sakellariou D and Manolis AS},
  year = {2010},
  journal = {International journal of clinical practice},
  doi = {10.1111/j.1742-1241.2010.02378.x},
  url = {https://doi.org/10.1111/j.1742-1241.2010.02378.x}
}

RIS

TY  - JOUR
TI  - Should we measure routinely oxidised and atherogenic dense low-density lipoproteins in subjects with type 2 diabetes?
AU  - Rizzo M
AU  - Berneis K
AU  - Koulouris S
AU  - Pastromas S
AU  - Rini GB
AU  - Sakellariou D
AU  - Manolis AS
PY  - 2010
JO  - International journal of clinical practice
DO  - 10.1111/j.1742-1241.2010.02378.x
UR  - https://doi.org/10.1111/j.1742-1241.2010.02378.x
ER  - 

APA

M, R., K, B., S, K., S, P., GB, R., D, S., & AS, M. (2010). Should we measure routinely oxidised and atherogenic dense low-density lipoproteins in subjects with type 2 diabetes?. International journal of clinical practice. https://doi.org/10.1111/j.1742-1241.2010.02378.x

Source records